Showing 1,181 - 1,200 results of 66,711 for search '(( 2 d decrease ) OR ( 50 ((((mean decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.31s Refine Results
  1. 1181
  2. 1182

    <i>In vitro</i> application of NGF decreased ATF3 expression in CGRP-positive neurons. by Ting Wang (16292)

    Published 2013
    “…<p>In control conditions (no growth factor), more than 90% of CGRP-positive neurons expressed ATF3 at 1 d (92.9±0.3%) (<b><i>A–C</i></b>; arrows) and 4 d (93.4±0.4%) (<b><i>G–I</i></b>; arrows) after plating. …”
  3. 1183

    Trial Sequential Analysis, parallel group trials, decreased appetite, nausea, vomiting, and abdominal pain. by Mathilde Holmskov (4112062)

    Published 2017
    “…<p>DARIS: diversity adjusted required information size; Pc: Event proportion in the control group; RRR: relative risk reduction in the intervention group; a: type I error; b: type II error; DIVERSITY: diversity (D-square). A) Decreased appetite: The required information size was 14,286 participants. …”
  4. 1184
  5. 1185
  6. 1186
  7. 1187
  8. 1188

    MT1-MMP gene silencing in both HUVECs and fibroblasts decreases endothelial sprout formation. by Pedro Correa de Sampaio (184186)

    Published 2012
    “…B – Quantification of endothelial cell sprouting showing a decrease in sprout formation with HUVECs expressing MT1-MMP shRNAs. …”
  9. 1189
  10. 1190
  11. 1191
  12. 1192
  13. 1193

    S-glutathionylation catalyst diamide also decreases ROS release from permeabilized skeletal muscle mitochondria. by Robert M. Gill (4854028)

    Published 2018
    “…The final concentration of pyruvate, 2-oxoglutarate, succinate, or palmitoyl-carnitine was 50 μM. n = 4, mean±SEM. (B) The decrease in mitochondrial ROS release correlates with an increase in overall protein S-glutathionylation. …”
  14. 1194
  15. 1195
  16. 1196

    The <i>rcan-1</i> rearrangement allele decreases expression of <i>rcan-1</i>. by Yuehui Zhao (3146229)

    Published 2020
    “…<p>(A) A volcano plot of expression differences between the <i>rcan-1</i> NIL1 and N2* strains. …”
  17. 1197
  18. 1198
  19. 1199

    KYNA and zaprinast decrease the [Ca<sup>2+</sup>]i plateau phase following an IP3-mediated stimulus in mouse cortical astrocytes. by Rolando Berlinguer-Palmini (491113)

    Published 2013
    “…<p><b>A</b>) A typical example of KYNA and zaprinast-induced decrease in somatic fluo-3 fluorescence time course measured in three different astrocytes in cultures: control (<i>upper panels</i>), in the presence of 10 μM KYNA (<i>middle panels</i>) or zaprinast 1 µM (<i>lower panels</i>). …”
  20. 1200